Patent · US Active

Antibodies, uses and methods

US11773175B2 · kind B2 · utility

0Cited by
131References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2021
Grant dateOct 3, 2023
Priority date
Expiry dateJul 30, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention related to anti-human OX40L antibodies, new medical uses and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.